NERV vs SLS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

NERV

47.3
AI Score
VS
NERV Wins

SLS

46.1
AI Score

Investment Advisor Scores

NERV

47score
Recommendation
HOLD

SLS

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV SLS Winner
Net Income -8.80M -29.20M NERV
Operating Income -7.51M -29.69M NERV
ROE -19.4% 763.1% SLS
ROA -7.9% -361.2% NERV
Total Assets 111.83M 8.09M NERV
Cash 80.14M 3.97M NERV
Current Ratio 24.32 0.44 NERV

Relative Price Performance (Last 90 Days)

NERV 1M: -33.3% · 3M: -45.3% SLS 1M: -3.7% · 3M: +6.5%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.6%), weak momentum, RSI 27

RSI (14): 27.3 · Price: $2.30

SLS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $11.54

Fundamentals Snapshot

Metric NERV SLS
Market Cap — —
Forward P/E -5.5 -115.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.8%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -36.12 -0.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NERV is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.